Blog https://www.qmenta.com/blog Latest Industry News in Ai analysis, Ai radiology and Neuroimaging en Fri, 25 Nov 2022 11:23:06 GMT 2022-11-25T11:23:06Z en QMENTA Successfully Completes External Security Audit https://www.qmenta.com/blog/qmenta-successfully-completes-external-security-audit <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/qmenta-successfully-completes-external-security-audit" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/Security-Audit.png" alt="QMENTA-Successfully-Completes-External-Security-Audit-lock" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="text-align: center;">&nbsp;</p> <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/qmenta-successfully-completes-external-security-audit" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/Security-Audit.png" alt="QMENTA-Successfully-Completes-External-Security-Audit-lock" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="text-align: center;">&nbsp;</p> <img src="https://track.hubspot.com/__ptq.gif?a=1553939&amp;k=14&amp;r=https%3A%2F%2Fwww.qmenta.com%2Fblog%2Fqmenta-successfully-completes-external-security-audit&amp;bu=https%253A%252F%252Fwww.qmenta.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> News Expertise Data Compliance Fri, 25 Nov 2022 11:23:06 GMT tim@qmenta.com (Tim Peeters) https://www.qmenta.com/blog/qmenta-successfully-completes-external-security-audit 2022-11-25T11:23:06Z The future of radiology, as told by its past https://www.qmenta.com/blog/the-future-of-radiology-as-told-by-its-past <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/the-future-of-radiology-as-told-by-its-past" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-Radiology-Day.png" alt="The future of radiology, as told by its past blog post" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="text-align: justify;">“A new scientific truth does not triumph by convincing its opponents and making them see the light, but rather because its opponents eventually die, and a new generation grows up that is familiar with it.”</p> <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/the-future-of-radiology-as-told-by-its-past" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-Radiology-Day.png" alt="The future of radiology, as told by its past blog post" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="text-align: justify;">“A new scientific truth does not triumph by convincing its opponents and making them see the light, but rather because its opponents eventually die, and a new generation grows up that is familiar with it.”</p> <img src="https://track.hubspot.com/__ptq.gif?a=1553939&amp;k=14&amp;r=https%3A%2F%2Fwww.qmenta.com%2Fblog%2Fthe-future-of-radiology-as-told-by-its-past&amp;bu=https%253A%252F%252Fwww.qmenta.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Expertise Clinical Trials Medical Imaging Tech Tue, 08 Nov 2022 07:58:35 GMT evie.neylon@qmenta.com (Evie Neylon) https://www.qmenta.com/blog/the-future-of-radiology-as-told-by-its-past 2022-11-08T07:58:35Z The top 4 open-source software tools to measure cortical brain thickness, volumetry and brain morphometry. https://www.qmenta.com/blog/the-top-4-open-source-software-tools-to-measure-cortical-brain-thickness-volumetry-and-brain-morphometry <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/the-top-4-open-source-software-tools-to-measure-cortical-brain-thickness-volumetry-and-brain-morphometry" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/Open-Source-Tools-FI.png" alt="The top 4 open-source software tools to measure cortical brain thickness, volumetry and brain morphometry." class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="text-align: justify;">Imaging trends and tools are evolving more than ever. There are many companies and technicians that are developing new algorithms to help researchers and clinical professionals to diagnose and measure disease progression efficiently.<br><br>There are many tools that are being developed every day, and despite the fact that some tools that we are going to discuss were made years ago, they are still the standard. Which shows how complicated it is to improve current results, widely accepted by the scientific community. That is the case of the following open source tools.</p> <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/the-top-4-open-source-software-tools-to-measure-cortical-brain-thickness-volumetry-and-brain-morphometry" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/Open-Source-Tools-FI.png" alt="The top 4 open-source software tools to measure cortical brain thickness, volumetry and brain morphometry." class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="text-align: justify;">Imaging trends and tools are evolving more than ever. There are many companies and technicians that are developing new algorithms to help researchers and clinical professionals to diagnose and measure disease progression efficiently.<br><br>There are many tools that are being developed every day, and despite the fact that some tools that we are going to discuss were made years ago, they are still the standard. Which shows how complicated it is to improve current results, widely accepted by the scientific community. That is the case of the following open source tools.</p> <img src="https://track.hubspot.com/__ptq.gif?a=1553939&amp;k=14&amp;r=https%3A%2F%2Fwww.qmenta.com%2Fblog%2Fthe-top-4-open-source-software-tools-to-measure-cortical-brain-thickness-volumetry-and-brain-morphometry&amp;bu=https%253A%252F%252Fwww.qmenta.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Research use Multiple Sclerosis Alzheimer Parkinson's Disease Neuroimaging Digital Biomarkers Mon, 16 May 2022 14:39:47 GMT https://www.qmenta.com/blog/the-top-4-open-source-software-tools-to-measure-cortical-brain-thickness-volumetry-and-brain-morphometry 2022-05-16T14:39:47Z Marc Ramos Multiple Sclerosis Clinical Trials and Drug Development History https://www.qmenta.com/blog/multiple-sclerosis-clinical-trials-and-drug-development-history <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/multiple-sclerosis-clinical-trials-and-drug-development-history" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-MSTimelines-8.png" alt="Multiple Sclerosis Clinical Trials and Drug Development History" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p>&nbsp;</p> <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/multiple-sclerosis-clinical-trials-and-drug-development-history" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-MSTimelines-8.png" alt="Multiple Sclerosis Clinical Trials and Drug Development History" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p>&nbsp;</p> <img src="https://track.hubspot.com/__ptq.gif?a=1553939&amp;k=14&amp;r=https%3A%2F%2Fwww.qmenta.com%2Fblog%2Fmultiple-sclerosis-clinical-trials-and-drug-development-history&amp;bu=https%253A%252F%252Fwww.qmenta.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Multiple Sclerosis Expertise Data Wed, 20 Apr 2022 13:56:07 GMT https://www.qmenta.com/blog/multiple-sclerosis-clinical-trials-and-drug-development-history 2022-04-20T13:56:07Z Oscar Peña Revolutionizing drug development for Parkinson's disease by using imaging biomarkers analysis tools. https://www.qmenta.com/blog/revolutionizing-drug-development-for-parkinsons-disease-by-using-imaging-biomarkers-analysis <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/revolutionizing-drug-development-for-parkinsons-disease-by-using-imaging-biomarkers-analysis" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-Parkinson-8.png" alt="Revolutionizing drug development for Parkinson's disease by using imaging biomarkers analysis tools." class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="text-align: justify;"><a href="https://www.epda.eu.com/about-parkinsons/what-is-parkinsons/">Parkinson’s Disease</a> is a progressive neurodegenerative disease characterized mainly by motor symptoms, however, it also causes non-motor symptoms. It mostly affects people above 60,&nbsp; more men than women, and its incidence increases with age. It has been estimated that more than 10 million people worldwide are suffering from Parkinson’s disease.</p> <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/revolutionizing-drug-development-for-parkinsons-disease-by-using-imaging-biomarkers-analysis" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-Parkinson-8.png" alt="Revolutionizing drug development for Parkinson's disease by using imaging biomarkers analysis tools." class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="text-align: justify;"><a href="https://www.epda.eu.com/about-parkinsons/what-is-parkinsons/">Parkinson’s Disease</a> is a progressive neurodegenerative disease characterized mainly by motor symptoms, however, it also causes non-motor symptoms. It mostly affects people above 60,&nbsp; more men than women, and its incidence increases with age. It has been estimated that more than 10 million people worldwide are suffering from Parkinson’s disease.</p> <img src="https://track.hubspot.com/__ptq.gif?a=1553939&amp;k=14&amp;r=https%3A%2F%2Fwww.qmenta.com%2Fblog%2Frevolutionizing-drug-development-for-parkinsons-disease-by-using-imaging-biomarkers-analysis&amp;bu=https%253A%252F%252Fwww.qmenta.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> News Expertise Clinical Trials Parkinson's Disease Medical Imaging Tech Fri, 01 Apr 2022 11:14:04 GMT tommy.boshkovski@qmenta.com (Tommy Boshkovski) https://www.qmenta.com/blog/revolutionizing-drug-development-for-parkinsons-disease-by-using-imaging-biomarkers-analysis 2022-04-01T11:14:04Z Top 5 Trends in Neuroscience You Need to Know in 2022 https://www.qmenta.com/blog/top-5-trends-in-neuroscience-you-need-to-know-in-2022 <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/top-5-trends-in-neuroscience-you-need-to-know-in-2022" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-Trends-8.png" alt="Top 5 Trends in Neuroscience You Need to Know in 2022" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="font-size: 20px;"><span style="font-family: Arial, Helvetica, sans-serif;">Advances in neuro-technology are accelerating at an astounding pace, and at times seem closer to science fiction than science fact. Let’s peer into the crystal ball and look ahead at the major neuroscience trends for 2022!</span></p> <h2 style="text-align: justify;"><span style="font-weight: bold;"></span></h2> <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/top-5-trends-in-neuroscience-you-need-to-know-in-2022" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-Trends-8.png" alt="Top 5 Trends in Neuroscience You Need to Know in 2022" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="font-size: 20px;"><span style="font-family: Arial, Helvetica, sans-serif;">Advances in neuro-technology are accelerating at an astounding pace, and at times seem closer to science fiction than science fact. Let’s peer into the crystal ball and look ahead at the major neuroscience trends for 2022!</span></p> <h2 style="text-align: justify;"><span style="font-weight: bold;"></span></h2> <img src="https://track.hubspot.com/__ptq.gif?a=1553939&amp;k=14&amp;r=https%3A%2F%2Fwww.qmenta.com%2Fblog%2Ftop-5-trends-in-neuroscience-you-need-to-know-in-2022&amp;bu=https%253A%252F%252Fwww.qmenta.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Expertise Mon, 20 Dec 2021 14:14:33 GMT https://www.qmenta.com/blog/top-5-trends-in-neuroscience-you-need-to-know-in-2022 2021-12-20T14:14:33Z Imaging Team Cloud AI Medical Imaging Expert QMENTA, Inc. Announces FDA 510(k) Clearance of Platform at RSNA 2021 https://www.qmenta.com/blog/cloud-ai-medical-imaging-expert-qmenta-inc.-announces-fda-510k-clearance-of-platform-at-rsna-2021 <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/cloud-ai-medical-imaging-expert-qmenta-inc.-announces-fda-510k-clearance-of-platform-at-rsna-2021" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-FDA-8.png" alt="Cloud AI Medical Imaging Expert QMENTA, Inc. Announces FDA 510(k) Clearance of Platform at RSNA 2021" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="text-align: center;"><span style="font-size: 16px;"><strong><span style="color: #000000;">Cloud AI Medical Imaging Expert QMENTA, Inc. Announces FDA 510(k) Clearance of Platform at RSNA 2021 </span></strong><strong><span style="color: #000000;"><br></span></strong></span><strong><span style="color: #000000;"><br></span></strong><span style="color: #000000;">QMENTA executives will be available in booth 6633 during the conference. </span><a href="https://neuroimaging.qmenta.com/rsna-2021?hsLang=en"><em><span>Schedule a meeting</span></em></a><em><span style="color: #000000;"> with QMENTA at RSNA to learn more.&nbsp;</span></em></p> <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/cloud-ai-medical-imaging-expert-qmenta-inc.-announces-fda-510k-clearance-of-platform-at-rsna-2021" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-FDA-8.png" alt="Cloud AI Medical Imaging Expert QMENTA, Inc. Announces FDA 510(k) Clearance of Platform at RSNA 2021" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="text-align: center;"><span style="font-size: 16px;"><strong><span style="color: #000000;">Cloud AI Medical Imaging Expert QMENTA, Inc. Announces FDA 510(k) Clearance of Platform at RSNA 2021 </span></strong><strong><span style="color: #000000;"><br></span></strong></span><strong><span style="color: #000000;"><br></span></strong><span style="color: #000000;">QMENTA executives will be available in booth 6633 during the conference. </span><a href="https://neuroimaging.qmenta.com/rsna-2021?hsLang=en"><em><span>Schedule a meeting</span></em></a><em><span style="color: #000000;"> with QMENTA at RSNA to learn more.&nbsp;</span></em></p> <img src="https://track.hubspot.com/__ptq.gif?a=1553939&amp;k=14&amp;r=https%3A%2F%2Fwww.qmenta.com%2Fblog%2Fcloud-ai-medical-imaging-expert-qmenta-inc.-announces-fda-510k-clearance-of-platform-at-rsna-2021&amp;bu=https%253A%252F%252Fwww.qmenta.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> News Expertise Press Release Mon, 29 Nov 2021 11:13:40 GMT https://www.qmenta.com/blog/cloud-ai-medical-imaging-expert-qmenta-inc.-announces-fda-510k-clearance-of-platform-at-rsna-2021 2021-11-29T11:13:40Z Paulo Rodrigues Countdown to RSNA 2021: Key Announcements from QMENTA, Booth 6633 https://www.qmenta.com/blog/rsna-2021-qmenta-booth-6633 <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/rsna-2021-qmenta-booth-6633" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-RSNA%20Countdown-8%20%281%29.png" alt="Countdown to RSNA 2021: Key Announcements from QMENTA, Booth 6633" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p>We’re thrilled to be back at RSNA 2021, and it is very fitting that it is the first in-person event we have attended since the pandemic. QMENTA has been making tremendous progress on many radiology fronts to empower breakthroughs in CNS diseases by solving some of our clients’ greatest challenges. We look forward to discussing them with you at the conference. Please be sure to check out our <a href="https://qmenta.com/">virtual press office</a> which has company news, executive profiles and product and services content for the media and all attendees. You can also schedule a meeting with us in booth 6633 through that site. Here is a quick recap of the major news we will be broadcasting in concert with RSNA.&nbsp;</p> <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/rsna-2021-qmenta-booth-6633" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-RSNA%20Countdown-8%20%281%29.png" alt="Countdown to RSNA 2021: Key Announcements from QMENTA, Booth 6633" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p>We’re thrilled to be back at RSNA 2021, and it is very fitting that it is the first in-person event we have attended since the pandemic. QMENTA has been making tremendous progress on many radiology fronts to empower breakthroughs in CNS diseases by solving some of our clients’ greatest challenges. We look forward to discussing them with you at the conference. Please be sure to check out our <a href="https://qmenta.com/">virtual press office</a> which has company news, executive profiles and product and services content for the media and all attendees. You can also schedule a meeting with us in booth 6633 through that site. Here is a quick recap of the major news we will be broadcasting in concert with RSNA.&nbsp;</p> <img src="https://track.hubspot.com/__ptq.gif?a=1553939&amp;k=14&amp;r=https%3A%2F%2Fwww.qmenta.com%2Fblog%2Frsna-2021-qmenta-booth-6633&amp;bu=https%253A%252F%252Fwww.qmenta.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Press Release Events Tue, 09 Nov 2021 08:18:00 GMT https://www.qmenta.com/blog/rsna-2021-qmenta-booth-6633 2021-11-09T08:18:00Z Chris M. Lindgren The Importance of Data Protection and Data Integrity in Imaging Clinical Trials https://www.qmenta.com/blog/the-importance-of-data-protection-and-data-integrity-in-imaging-clinical-trials <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/the-importance-of-data-protection-and-data-integrity-in-imaging-clinical-trials" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-Platform2.0.png" alt="The Importance of Data Protection and Data Integrity in Imaging Clinical Trials" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="inner-wrap animated"> <div class="post-content" style="text-align: left;"> <div class="content-inner" style="text-align: center;"> <h2 style="text-align: center;"><span style="color: #292929;"><em><span style="font-weight: normal;">QMENTA’s Key Enhancements Are Critical Enablers of Success in Clinical Studies</span></em></span></h2> <p style="text-align: justify;"><span style="color: #292929;">At QMENTA, we’re on a mission to empower breakthroughs that make brain diseases a thing of the past through our AI-powered neuroimaging and clinical data management and analysis capabilities.&nbsp;</span></p> <p style="text-align: justify;"><span style="color: #292929;">The QMENTA Platform streamlines image management workflows to make it easier to transfer, manage, analyze, and read medical images for your clinical studies providing more accurate results, faster and with less risk. Our solution has been purpose-built for healthcare data from the outset with the highest quality, privacy and security standards in the industry. We have always adopted a culture of continuous improvement as we work closely with leading global CROs, biopharma and neurology experts, and we recently introduced several new improvements to make Data Protection and Data Integrity even more streamlined and easy to implement.</span></p> <p style="text-align: justify;"><span style="color: #292929;">Clinical data management is resource intensive and<span> potentially comes with large compliance, cybersecurity, scientific and regulatory risks.</span>&nbsp;Imaging based studies in particular involve collecting, processing and securing vast quantities of data.&nbsp;</span></p> <p style="text-align: justify;"><span style="color: #292929;">Let’s take a typical Alzheimer’s Disease phase II clinical trial, as an example:</span></p> <ul style="text-align: justify;"> <li> <p><span style="color: #292929;">Requires the collection of multi-modal imaging data (MRI, PET);</span></p> </li> <li> <p><span style="color: #292929;">includes 100-200 participants, with multiple acquisition time points across 2 years;</span></p> </li> <li> <p><span style="color: #292929;">from dozens of different sites across the globe (US, EU, Australia, etc.).</span></p> </li> </ul> <p style="text-align: justify;"><span style="color: #292929;">The study involves several imaging endpoints:</span></p> <ul style="text-align: justify;"> <li> <p><span style="color: #292929;">Changes of total brain volume and hippocampal volume as detected in volumetric MRI;</span></p> </li> <li> <p><span style="color: #292929;">changes in white-matter quality measured by Diffusion Tensor Imaging (DTI);</span></p> </li> <li> <p><span style="color: #292929;">brain amyloid PET levels will be measured with Positron Emission Tomography (PET).&nbsp;</span></p> </li> </ul> <p style="text-align: justify;"><span style="color: #292929;">As with this example, we see clinical trials becoming more complex, personalized and challenged with an explosion of patient data. Collecting, managing, quality control and reading of imaging data across multiple sites, scanners, and file types can be time-consuming, resource-intensive and error-prone. Furthermore, CROs and sponsors have to comply with the highest security and regulatory standards, in a globalized environment. In the U.S., the Health Insurance Portability and Accountability Act (HIPAA) and Health Information Technology for Economic and Clinical Health (HITECH) are the priorities, whereas, European trials look to the EU’s recent General Data Protection Regulation (GDPR).</span></p> <p style="text-align: justify;"><span style="color: #292929;">Having assurance of privacy, security and integrity in your data management and user access controls is critically important especially as sponsors transition more and more to decentralized trials and researchers rely on global research collaborations.&nbsp;</span><span style="color: #333333;"><a href="https://www.qmenta.com/" style="color: #00758c; font-weight: normal;"></a></span></p> <h5 style="text-align: justify;"><span style="font-weight: bold; color: #292929;">Global Clinical Trials require a unified, data-centric approach to privacy, security, and integrity.<br></span></h5> <p style="text-align: justify;"><span style="font-weight: normal; color: #292929;">COVID-19 accelerated our transition to digital-based methodologies. Tremendous opportunities abound but it requires highly technical and consistent standardized methods to maintain the highest data integrity and manage risks given the huge investments made by biopharma sponsors, CROs and research entities. The <a href="https://www.msif.org/covid-19-ms-global-data-sharing-initiative/" style="text-decoration: underline;">COVID-19 Global Data Sharing Initiative</a> which leverages the QMENTA platform is a fantastic example of how to set up a GDPR-compliant data collection, and processing pipeline. </span><br></p> <p style="text-align: justify;"><span style="font-weight: normal; color: #292929;">Other key benefits of a risk-mitigated strategy include substantial time and cost savings, accelerated milestones and approvable submissions data. Depending on your organizational focus and its resources and goals, various strategies for success can be undertaken.</span></p> <h5 style="text-align: justify;"><span style="color: #292929;"><strong>Benefits to be reaped include highly usable and approvable data</strong></span></h5> <p style="text-align: justify;"><span style="font-weight: normal; color: #292929;">At QMENTA, by design, we streamline medical imaging studies, end-to-end. Aggregating and integrating very complex imaging data in the cloud and making it highly usable for activities such as AI-enabled imaging analysis using biomarkers is essential to scientific endeavors. Optimizing compliant data collection, automated recognition and classification, de-identification, integration and quality assurance is intrinsic to successful outcomes. But just as important are some other mission critical Data Protection factors which our recent release further strengthened.&nbsp;</span></p> <h5 style="text-align: justify;"><span style="color: #292929;">QMENTA’s 2.0 Platform release deeply enhances security and GxP compliance <br><br><span style="font-weight: normal;">Key highlights include:</span><br><br></span><span style="font-weight: normal; color: #292929;"><span style="font-weight: bold;">Enables Audit Readiness: </span>You can easily demonstrate compliance with comprehensive and detailed audit trails capturing every event in data history, including document approvers, status changes, execution of a signature, authentication, and more. </span><br><br><span style="font-weight: normal; color: #292929;"><span style="font-weight: bold;">Improves GxP Quality and Compliance: </span>We improved several features that help assure GCP compliance by the investigator and/or sponsor. </span><br><br><span style="font-weight: normal; color: #292929;"><span style="font-weight: bold;">Provides Custom Electronic Signature and Manifestation:</span> Approve data upload using electronic signatures and manifestations that are compliant with FDA Title 21 CFR Part 11 and Annex 11.</span><br><br><span style="font-weight: normal; color: #292929;"><span style="font-weight: bold;">Facilitates Two-Factor authentication (2FA): </span>Besides having Password Security Policies for users to access and provide e-Signatures in QMENTA Platform, 2FA can now be enabled for a study, requiring users to authenticate via SMS code.</span><strong><br></strong></h5> <p style="text-align: justify;">&nbsp;</p> <p style="text-align: center;"> <span style="font-size: 14px; color: #292929;">QMENTA Neuroimaging Software Solutions for Global Clinical Trials: Cloud-based, AI-powered.</span></p> <p style="text-align: center;">&nbsp;</p> <p style="text-align: justify;"><span style="color: #292929; font-family: 'Nunito Sans'; font-size: 18px; font-weight: bold; letter-spacing: 0px;">Very significant ROI and outcomes are to be gained from a secure, cloud based approach</span></p> <p style="text-align: justify;"><span style="color: #292929;">QMENTA’s recent 2.0 platform release focused on key enhancements to our security capabilities so that our clients and strategic partners can have full confidence in the level of risk mitigation they have working for them to accelerate high quality results. More importantly, combined with the data aggregation and curation performed on our platform and high usability of the resulting data for analytical purposes, there is a huge amount of time and cost savings to be reaped. This allows companies to accelerate their digital transformation and speed to discovery and the clinic or market through a strategic, trusted partnership.</span></p> <p style="text-align: justify;"><span style="color: #292929;">As always, an enormous thank you to our trusted users and partners who continue to help shape the future of neurology data management.</span></p> <h5>Interested to know more?</h5> <h5 style="line-height: 1;">Get in touch with our team for a demo meeting or sign up and try it for free.</h5> <p style="line-height: 1;">&nbsp;</p> <p style="text-align: center; line-height: 1;"><a class="cta_button" href="https://www.qmenta.com/cs/ci/?pg=43db42f5-be98-4a66-9e8c-0e2f85e026d8&amp;pid=1553939&amp;ecid=&amp;hseid=&amp;hsic="><img class="hs-cta-img " style="border-width: 0px; /*hs-extra-styles*/; " alt="DOWNLOAD BROCHURE" src="https://no-cache.hubspot.com/cta/default/1553939/43db42f5-be98-4a66-9e8c-0e2f85e026d8.png"></a></p> <p style="text-align: center; line-height: 1;"><a class="cta_button" href="https://www.qmenta.com/cs/ci/?pg=93c8f8eb-981a-4894-94eb-c4a29b825c7d&amp;pid=1553939&amp;ecid=&amp;hseid=&amp;hsic="><img class="hs-cta-img " style="border-width: 0px; /*hs-extra-styles*/; " alt="FREE ACCOUNT" src="https://no-cache.hubspot.com/cta/default/1553939/93c8f8eb-981a-4894-94eb-c4a29b825c7d.png"></a></p> </div> </div> </div> <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/the-importance-of-data-protection-and-data-integrity-in-imaging-clinical-trials" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-Platform2.0.png" alt="The Importance of Data Protection and Data Integrity in Imaging Clinical Trials" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="inner-wrap animated"> <div class="post-content" style="text-align: left;"> <div class="content-inner" style="text-align: center;"> <h2 style="text-align: center;"><span style="color: #292929;"><em><span style="font-weight: normal;">QMENTA’s Key Enhancements Are Critical Enablers of Success in Clinical Studies</span></em></span></h2> <p style="text-align: justify;"><span style="color: #292929;">At QMENTA, we’re on a mission to empower breakthroughs that make brain diseases a thing of the past through our AI-powered neuroimaging and clinical data management and analysis capabilities.&nbsp;</span></p> <p style="text-align: justify;"><span style="color: #292929;">The QMENTA Platform streamlines image management workflows to make it easier to transfer, manage, analyze, and read medical images for your clinical studies providing more accurate results, faster and with less risk. Our solution has been purpose-built for healthcare data from the outset with the highest quality, privacy and security standards in the industry. We have always adopted a culture of continuous improvement as we work closely with leading global CROs, biopharma and neurology experts, and we recently introduced several new improvements to make Data Protection and Data Integrity even more streamlined and easy to implement.</span></p> <p style="text-align: justify;"><span style="color: #292929;">Clinical data management is resource intensive and<span> potentially comes with large compliance, cybersecurity, scientific and regulatory risks.</span>&nbsp;Imaging based studies in particular involve collecting, processing and securing vast quantities of data.&nbsp;</span></p> <p style="text-align: justify;"><span style="color: #292929;">Let’s take a typical Alzheimer’s Disease phase II clinical trial, as an example:</span></p> <ul style="text-align: justify;"> <li> <p><span style="color: #292929;">Requires the collection of multi-modal imaging data (MRI, PET);</span></p> </li> <li> <p><span style="color: #292929;">includes 100-200 participants, with multiple acquisition time points across 2 years;</span></p> </li> <li> <p><span style="color: #292929;">from dozens of different sites across the globe (US, EU, Australia, etc.).</span></p> </li> </ul> <p style="text-align: justify;"><span style="color: #292929;">The study involves several imaging endpoints:</span></p> <ul style="text-align: justify;"> <li> <p><span style="color: #292929;">Changes of total brain volume and hippocampal volume as detected in volumetric MRI;</span></p> </li> <li> <p><span style="color: #292929;">changes in white-matter quality measured by Diffusion Tensor Imaging (DTI);</span></p> </li> <li> <p><span style="color: #292929;">brain amyloid PET levels will be measured with Positron Emission Tomography (PET).&nbsp;</span></p> </li> </ul> <p style="text-align: justify;"><span style="color: #292929;">As with this example, we see clinical trials becoming more complex, personalized and challenged with an explosion of patient data. Collecting, managing, quality control and reading of imaging data across multiple sites, scanners, and file types can be time-consuming, resource-intensive and error-prone. Furthermore, CROs and sponsors have to comply with the highest security and regulatory standards, in a globalized environment. In the U.S., the Health Insurance Portability and Accountability Act (HIPAA) and Health Information Technology for Economic and Clinical Health (HITECH) are the priorities, whereas, European trials look to the EU’s recent General Data Protection Regulation (GDPR).</span></p> <p style="text-align: justify;"><span style="color: #292929;">Having assurance of privacy, security and integrity in your data management and user access controls is critically important especially as sponsors transition more and more to decentralized trials and researchers rely on global research collaborations.&nbsp;</span><span style="color: #333333;"><a href="https://www.qmenta.com/" style="color: #00758c; font-weight: normal;"></a></span></p> <h5 style="text-align: justify;"><span style="font-weight: bold; color: #292929;">Global Clinical Trials require a unified, data-centric approach to privacy, security, and integrity.<br></span></h5> <p style="text-align: justify;"><span style="font-weight: normal; color: #292929;">COVID-19 accelerated our transition to digital-based methodologies. Tremendous opportunities abound but it requires highly technical and consistent standardized methods to maintain the highest data integrity and manage risks given the huge investments made by biopharma sponsors, CROs and research entities. The <a href="https://www.msif.org/covid-19-ms-global-data-sharing-initiative/" style="text-decoration: underline;">COVID-19 Global Data Sharing Initiative</a> which leverages the QMENTA platform is a fantastic example of how to set up a GDPR-compliant data collection, and processing pipeline. </span><br></p> <p style="text-align: justify;"><span style="font-weight: normal; color: #292929;">Other key benefits of a risk-mitigated strategy include substantial time and cost savings, accelerated milestones and approvable submissions data. Depending on your organizational focus and its resources and goals, various strategies for success can be undertaken.</span></p> <h5 style="text-align: justify;"><span style="color: #292929;"><strong>Benefits to be reaped include highly usable and approvable data</strong></span></h5> <p style="text-align: justify;"><span style="font-weight: normal; color: #292929;">At QMENTA, by design, we streamline medical imaging studies, end-to-end. Aggregating and integrating very complex imaging data in the cloud and making it highly usable for activities such as AI-enabled imaging analysis using biomarkers is essential to scientific endeavors. Optimizing compliant data collection, automated recognition and classification, de-identification, integration and quality assurance is intrinsic to successful outcomes. But just as important are some other mission critical Data Protection factors which our recent release further strengthened.&nbsp;</span></p> <h5 style="text-align: justify;"><span style="color: #292929;">QMENTA’s 2.0 Platform release deeply enhances security and GxP compliance <br><br><span style="font-weight: normal;">Key highlights include:</span><br><br></span><span style="font-weight: normal; color: #292929;"><span style="font-weight: bold;">Enables Audit Readiness: </span>You can easily demonstrate compliance with comprehensive and detailed audit trails capturing every event in data history, including document approvers, status changes, execution of a signature, authentication, and more. </span><br><br><span style="font-weight: normal; color: #292929;"><span style="font-weight: bold;">Improves GxP Quality and Compliance: </span>We improved several features that help assure GCP compliance by the investigator and/or sponsor. </span><br><br><span style="font-weight: normal; color: #292929;"><span style="font-weight: bold;">Provides Custom Electronic Signature and Manifestation:</span> Approve data upload using electronic signatures and manifestations that are compliant with FDA Title 21 CFR Part 11 and Annex 11.</span><br><br><span style="font-weight: normal; color: #292929;"><span style="font-weight: bold;">Facilitates Two-Factor authentication (2FA): </span>Besides having Password Security Policies for users to access and provide e-Signatures in QMENTA Platform, 2FA can now be enabled for a study, requiring users to authenticate via SMS code.</span><strong><br></strong></h5> <p style="text-align: justify;">&nbsp;</p> <p style="text-align: center;"> <span style="font-size: 14px; color: #292929;">QMENTA Neuroimaging Software Solutions for Global Clinical Trials: Cloud-based, AI-powered.</span></p> <p style="text-align: center;">&nbsp;</p> <p style="text-align: justify;"><span style="color: #292929; font-family: 'Nunito Sans'; font-size: 18px; font-weight: bold; letter-spacing: 0px;">Very significant ROI and outcomes are to be gained from a secure, cloud based approach</span></p> <p style="text-align: justify;"><span style="color: #292929;">QMENTA’s recent 2.0 platform release focused on key enhancements to our security capabilities so that our clients and strategic partners can have full confidence in the level of risk mitigation they have working for them to accelerate high quality results. More importantly, combined with the data aggregation and curation performed on our platform and high usability of the resulting data for analytical purposes, there is a huge amount of time and cost savings to be reaped. This allows companies to accelerate their digital transformation and speed to discovery and the clinic or market through a strategic, trusted partnership.</span></p> <p style="text-align: justify;"><span style="color: #292929;">As always, an enormous thank you to our trusted users and partners who continue to help shape the future of neurology data management.</span></p> <h5>Interested to know more?</h5> <h5 style="line-height: 1;">Get in touch with our team for a demo meeting or sign up and try it for free.</h5> <p style="line-height: 1;">&nbsp;</p> <p style="text-align: center; line-height: 1;"><a class="cta_button" href="https://www.qmenta.com/cs/ci/?pg=43db42f5-be98-4a66-9e8c-0e2f85e026d8&amp;pid=1553939&amp;ecid=&amp;hseid=&amp;hsic="><img class="hs-cta-img " style="border-width: 0px; /*hs-extra-styles*/; " alt="DOWNLOAD BROCHURE" src="https://no-cache.hubspot.com/cta/default/1553939/43db42f5-be98-4a66-9e8c-0e2f85e026d8.png"></a></p> <p style="text-align: center; line-height: 1;"><a class="cta_button" href="https://www.qmenta.com/cs/ci/?pg=93c8f8eb-981a-4894-94eb-c4a29b825c7d&amp;pid=1553939&amp;ecid=&amp;hseid=&amp;hsic="><img class="hs-cta-img " style="border-width: 0px; /*hs-extra-styles*/; " alt="FREE ACCOUNT" src="https://no-cache.hubspot.com/cta/default/1553939/93c8f8eb-981a-4894-94eb-c4a29b825c7d.png"></a></p> </div> </div> </div> <img src="https://track.hubspot.com/__ptq.gif?a=1553939&amp;k=14&amp;r=https%3A%2F%2Fwww.qmenta.com%2Fblog%2Fthe-importance-of-data-protection-and-data-integrity-in-imaging-clinical-trials&amp;bu=https%253A%252F%252Fwww.qmenta.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> News Expertise Data Tue, 05 Oct 2021 08:30:46 GMT https://www.qmenta.com/blog/the-importance-of-data-protection-and-data-integrity-in-imaging-clinical-trials 2021-10-05T08:30:46Z Paulo Rodrigues QMENTA Launches AI Imaging Biomarker Analysis Catalog at RSNA 2021 https://www.qmenta.com/blog/ai-imaging-biomarker-analysis-catalog-at-rsna-2021 <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/ai-imaging-biomarker-analysis-catalog-at-rsna-2021" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-ToolsCatalog-8%20%281%29.png" alt="QMENTA Launches AI Imaging Biomarker Analysis Catalog at RSNA 2021" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="inner-wrap animated"> <div class="post-content"> <div class="content-inner"> <h2 style="text-align: center;"><em>The QMENTA Medical Imaging AI Analyses Catalog and Disease Biomarker Packages are a first-in-industry solution that aggregates and curates industry standard and proprietary AI tools.&nbsp;</em><br><span style="font-weight: normal;"></span></h2> </div> </div> </div> <div class="hs-featured-image-wrapper"> <a href="https://www.qmenta.com/blog/ai-imaging-biomarker-analysis-catalog-at-rsna-2021" title="" class="hs-featured-image-link"> <img src="https://www.qmenta.com/hubfs/FI-ToolsCatalog-8%20%281%29.png" alt="QMENTA Launches AI Imaging Biomarker Analysis Catalog at RSNA 2021" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="inner-wrap animated"> <div class="post-content"> <div class="content-inner"> <h2 style="text-align: center;"><em>The QMENTA Medical Imaging AI Analyses Catalog and Disease Biomarker Packages are a first-in-industry solution that aggregates and curates industry standard and proprietary AI tools.&nbsp;</em><br><span style="font-weight: normal;"></span></h2> </div> </div> </div> <img src="https://track.hubspot.com/__ptq.gif?a=1553939&amp;k=14&amp;r=https%3A%2F%2Fwww.qmenta.com%2Fblog%2Fai-imaging-biomarker-analysis-catalog-at-rsna-2021&amp;bu=https%253A%252F%252Fwww.qmenta.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> News Press Release Data Thu, 30 Sep 2021 14:50:16 GMT https://www.qmenta.com/blog/ai-imaging-biomarker-analysis-catalog-at-rsna-2021 2021-09-30T14:50:16Z Chris M. Lindgren